VD
Vidhi Dilip Shanghvi
About Vidhi Dilip Shanghvi
Data last updated:
Vidhi Dilip Shanghvi is a Whole-Time Director at Sun Pharmaceutical Industries Limited (since 2025), Director at Sun Petrochemicals Private Limited (since 2022) and Director at Vivaldis Health And Foods Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Pharma, Metals and Minerals and Business Outsourcing. The 6 current companies with reported revenue have a combined latest revenue of ₹62,597 Cr; the largest is Sun Pharmaceutical Industries Limited at ₹60,434 Cr (FY 2026). Earlier, Vidhi Dilip Shanghvi was a Director at Rayo Nutrition Private Limited (2013–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Pharmaceutical Industries Limited L24230GJ1993PLC019050 | Whole-Time Director | 22 May 2025 | 1993 | ₹60,434 Cr (FY 2026) | Active |
 Sun Petrochemicals Private Limited U24219MH1995PTC464242 | Director | 24 Mar 2022 | 1995 | ₹2,008 Cr (FY 2025) | Active |
 Vivaldis Health And Foods Private Limited U24297PN2014PTC150393 | Director | 11 May 2023 | 2014 | ₹81.41 Cr (FY 2025) | Active |
 Sun Pharma Advanced Research Company Limited L73100GJ2006PLC047837 | Director | 15 Jul 2024 | 2006 | ₹73.56 Cr (FY 2025) | Active |
 Sun Petro Private Limited U35100MH1990PTC465129 | Additional Director | 06 Jan 2026 | 1990 | ₹4.7 Lakh (FY 2025) | Active |
| Iti Finvest Limited U65100MH2016PLC272304 | Director | 22 Jan 2016 | 2016 | ₹6,000 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Rayo Nutrition Private Limited U74120MH2013PTC242724 | Director | 01 May 2013 | 2013 | ₹1.62 Cr (FY 2020) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vidhi Dilip Shanghvi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vidhi Dilip Shanghvi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vidhi Dilip Shanghvi
Vidhi Dilip Shanghvi currently holds 6 directorships: Sun Pharmaceutical Industries Limited (Whole-Time Director, since 22 May 2025, revenue ₹60,434 Cr (FY 2026)); Sun Petrochemicals Private Limited (Director, since 24 Mar 2022, revenue ₹2,008 Cr (FY 2025)); Vivaldis Health And Foods Private Limited (Director, since 11 May 2023, revenue ₹81.41 Cr (FY 2025)); Sun Pharma Advanced Research Company Limited (Director, since 15 Jul 2024, revenue ₹73.56 Cr (FY 2025)); Sun Petro Private Limited (Additional Director, since 06 Jan 2026, revenue ₹4.7 Lakh (FY 2025)); and 1 more.
Vidhi Dilip Shanghvi was first appointed on 01 May 2013 as Director at Rayo Nutrition Private Limited. The most recent appointment on record is 06 Jan 2026 at Sun Petro Private Limited.
The 6 current companies of Vidhi Dilip Shanghvi that report revenue have a combined latest revenue of ₹62,597 Cr: Sun Pharmaceutical Industries Limited ₹60,434 Cr (FY 2026); Sun Petrochemicals Private Limited ₹2,008 Cr (FY 2025); Vivaldis Health And Foods Private Limited ₹81.41 Cr (FY 2025); Sun Pharma Advanced Research Company Limited ₹73.56 Cr (FY 2025); Sun Petro Private Limited ₹4.7 Lakh (FY 2025); and 1 more.
Vidhi Dilip Shanghvi held 1 earlier board appointment: Rayo Nutrition Private Limited (Director, 01 May 2013 to 18 Nov 2019).
The current boards of Vidhi Dilip Shanghvi's companies include Aalok Dilip Shanghvi (Sun Pharmaceutical Industries Limited), Andreas Eugen Busch (Sun Pharmaceutical Industries Limited), Anoop Anjanikumar Deshpande (Sun Pharmaceutical Industries Limited), Dilip Shantilal Shanghvi (Sun Pharmaceutical Industries Limited), Gautam Bhailal Doshi (Sun Pharmaceutical Industries Limited), Jayashree Satagopan (Sun Pharmaceutical Industries Limited), among others.